Read More Pharma Industry News Roivant Sciences enters into $7.3bn merger with Montes Archimedes Acquisition Roivant Sciences has agreed to merge with Montes Archimedes Acquisition (MAAC), a Nasdaq-listed special purpose acquisition company, in… bySrinathMay 4, 2021